Traders Buy Large Volume of SIGA Technologies Call Options (NASDAQ:SIGA)

SIGA Technologies, Inc. (NASDAQ:SIGA) was the recipient of unusually large options trading on Wednesday. Stock traders purchased 1,200 call options on the stock. This represents an increase of 1,438% compared to the typical volume of 78 call options.

Institutional Trading of SIGA Technologies

A number of hedge funds and other institutional investors have recently made changes to their positions in SIGA. Larson Financial Group LLC bought a new stake in SIGA Technologies during the 3rd quarter worth about $30,000. DekaBank Deutsche Girozentrale acquired a new stake in shares of SIGA Technologies in the second quarter valued at approximately $40,000. China Universal Asset Management Co. Ltd. raised its position in SIGA Technologies by 64.3% in the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 13,727 shares of the company’s stock worth $93,000 after purchasing an additional 5,372 shares during the last quarter. Bayesian Capital Management LP acquired a new position in SIGA Technologies during the 1st quarter worth $97,000. Finally, AQR Capital Management LLC bought a new position in SIGA Technologies in the 2nd quarter valued at $99,000. 55.40% of the stock is currently owned by institutional investors and hedge funds.

SIGA Technologies Stock Performance

Shares of NASDAQ:SIGA opened at $6.61 on Thursday. The company has a market capitalization of $471.95 million, a PE ratio of 5.59 and a beta of 0.89. The company’s fifty day moving average is $7.27 and its 200-day moving average is $8.03. SIGA Technologies has a 52 week low of $4.26 and a 52 week high of $12.83.

SIGA Technologies (NASDAQ:SIGA) last issued its quarterly earnings data on Thursday, November 7th. The company reported $0.02 earnings per share for the quarter. The firm had revenue of $10.01 million for the quarter. SIGA Technologies had a net margin of 49.33% and a return on equity of 49.06%. On average, analysts forecast that SIGA Technologies will post 1.01 EPS for the current year.

About SIGA Technologies

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.